Long-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diabetes

Authors

Michelle D. Lundholm, Cleveland Clinic Foundation
Sarah Kirschling, Cleveland Clinic Foundation
Bo Hu, Cleveland Clinic Foundation
Ali Aminian, Cleveland Clinic Foundation
David E. Arterburn, Kaiser Permanente
Anita P. Courcoulas, University of Pittsburgh School of Medicine
David E. Cummings, VA Puget Sound Health Care System
William F. Gourash, University of Pittsburgh School of Medicine
Mary Elizabeth Patti, Harvard Medical School
Philip R. Schauer, Pennington Biomedical Research Center
Donald C. Simonson, Harvard Medical School
Ashley H. Vernon, Harvard Medical School
John P. Kirwan, Pennington Biomedical Research Center
Sangeeta R. Kashyap, Weill Cornell Medicine

Document Type

Letter to the Editor

Publication Date

12-1-2024

Recommended Citation

Lundholm, M., Kirschling, S., Hu, B., Aminian, A., Arterburn, D., Courcoulas, A., Cummings, D., Gourash, W., Patti, M., Schauer, P., Simonson, D., Vernon, A., Kirwan, J., & Kashyap, S. (2024). Long-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diabetes. Retrieved from https://repository.lsu.edu/pbrc_basic_science_pubs/143